Historical record - last NADAC effective date: 4/17/2019
Product Information
FLURBIPROFEN 0.03% EYE DROP is a generic product labeled by Bausch & Lomb Incorporated, priced at $11.2147 per ML under NDC 24208031425. Its NADAC has been published 287 times since Nov 28, 2013.
FDA first approved this application on Jan 4, 1995.
Strength
.3 mg/mL
Manufacturer
Bausch & Lomb IncorporatedNDC
24208031425
Classification
Generic
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Effective Date
4/17/2019
Active Ingredients
FLURBIPROFEN SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA074447FDA Approved
1/4/1995
On Market Since
1/4/1995
Pharmacological Classes
Price Statistics
The NADAC for FLURBIPROFEN 0.03% EYE DROP has been published 287 times since Nov 28, 2013, and over the history we have for it it has risen 605.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $11.2147 per ML |
|---|---|
| All-time high | $11.2147 (May 22, 2019) |
| All-time low | $1.3500 (Mar 21, 2018) |
| Median price | $1.5781 |
| Average price | $1.7871 |
| Largest weekly change | +522.3% (Apr 17, 2019) |
| Weeks tracked | 287 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+605.7%
Last surveyed May 22, 2019 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 12% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Bausch & Lomb Incorporated manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Flurbiprofen Sodium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nonsteroidal Anti-inflammatory Drug class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FLURBIPROFEN 0.03% EYE DROP?
The current National Average Drug Acquisition Cost (NADAC) for FLURBIPROFEN 0.03% EYE DROP, manufactured by Bausch & Lomb Incorporated, is $11.2147 per ML (NDC 24208031425), effective May 22, 2019.
How has the price of FLURBIPROFEN 0.03% EYE DROP changed over time?
Over the history we have for it, the NADAC for FLURBIPROFEN 0.03% EYE DROP has risen 605.7%. It has been tracked across 287 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for FLURBIPROFEN 0.03% EYE DROP?
Since Nov 28, 2013, the NADAC for FLURBIPROFEN 0.03% EYE DROP has ranged from a low of $1.3500 (Mar 21, 2018) to a high of $11.2147 (May 22, 2019), with a median of $1.5781 per ML.
Are there cheaper alternatives to FLURBIPROFEN 0.03% EYE DROP?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, FLURBIPROFEN 0.03% EYE DROP, is $9.8292 per ML — about 12% below FLURBIPROFEN 0.03% EYE DROP.
Who manufactures FLURBIPROFEN 0.03% EYE DROP?
FLURBIPROFEN 0.03% EYE DROP (NDC 24208031425) is labeled by Bausch & Lomb Incorporated, and CMS classifies it as a generic product.